Vandervoort Adam C, Chief Legal Officer, Secretary, subtracted 3,525 shares of Teladoc Health, Inc. (TDOC) from its portfolio at the rate of $79.12 per share valuing $278,898 on Nov 08. The insider left behind 200 shares of the company to its portfolio. Currently, the 1st Resistance Point for this stock is $80.14, with a 2nd Resistance Point sitting at $81.40. Meanwhile, this company’s stock has a 1st Support Level at $76.65 and a 2nd Support Level at $74.42. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Teladoc Health, Inc. (TDOC) was $78.88. Teladoc Health, Inc. (TDOC) stock has lost -$5.08, or -7.09%, in the past five days. In the last full month, these shares have gained $0.52, or 0.66%. In the past three months, this stock’s price has risen by $22.41, or 39.68%. This year-to-date, Teladoc Health, Inc. (TDOC) shares have gained $29.31, or 59.13%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Teladoc Health, Inc. (TDOC) stock, 50% of short-term indicators suggest that these shares are a “ Hold .” Meanwhile, 100% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 100% of long-term indicators suggest that this stock is a “ Buy .”
With 72,382 K shares outstanding, this company currently has a market capitalization of $5,677,645K. Teladoc Health, Inc. (TDOC) generates $417,910 K in annual sales, amounting to annual net income of -$97,080 K. This stock has generated a 1-Year Total Return of 21.58%, a 3-Year Total Return of 343.16%, and a 5-year Total Return of 0.00%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.
In the most recently-reported fiscal quarter, which ended in 09/19, Teladoc Health, Inc. (TDOC) reported earnings of -$0.39 per share. Wall Street analysts, on average, were expecting the company to report earnings of -$0.40 per share, representing a 0.01 difference and 2.50% surprise. In the previous quarter ending in 06/19, the reported earnings of -$0.41 represented a -0.01 difference from the consensus estimate calling for -$0.40 per share, which was a -2.50% surprise.
For the current fiscal quarter, which is set to end in 12/2019, the average earnings estimate is -$0.33 per share. This estimate came from a total of 12 Wall Street Analysts. Of those market experts, the high estimate was -$0.26 and the low estimate was -$0.40. In the year-ago quarter, Teladoc Health, Inc. (TDOC) generated per-share earnings of -$0.35. If the analysts are correct about the current quarter’s earnings, the growth will be +5.71%.
Turning our focus now to insider trading activity, there have been 22 purchases (71,772 shares in total) and 9 sale (78,607 shares in total) in the last 3 months. In the last 6 months, there have been 45 insider buys amounting to 163,539 shares and 26 insider sales amounting to 168,907 shares. In the past full year, 112 insider purchases were made (involving 650,620 shares) and 60 insider sell-offs equivalent to 488,960 shares.
Moving onto liquidity, Teladoc Health, Inc. (TDOC) has a Current Ratio of 8.53, a Quick Ratio of 8.53 and a Cash Ratio of 7.66. Looking at this company’s capital structure, its Total Debt to Total Equity is 40.93, its Total Debt to Total Capital is 29.04, and its Total Debt to Total Assets is now 26.07. Looking even further ahead into the future, its Long-Term Debt to Equity is -2.52 and its Long-Term Debt to Total Capital is 40.93.